Gene therapy demand drives VGXI to up Texan GMP capabilities
DNA manufacturing and development services VGXI will add two new facilities in response to increased demand for gene therapy products.
Archives for February 28, 2018
CEL-SCI patent allows for LEAPS vaccine platform expansion
A newly approved patent will allow CEL-SCI to explore using cellular delivery to prevent and treat infectious diseases using its LEAPS technology, the firm says.
Xencor extends ‘plug-and-play’ deal with Selexis, signs four mAbs
Xencor and Selexis will extend their strategic partnership with the signing of four commercial license agreements to advance XmAb bispecific antibody drug candidates.